The medical device innovation consortium has proposed a voluntary program using the maturity model as a predictor of quality achievement that may result in some easing of FDA submission requirements for a high-ranking company. Is this a good idea? Why or why not? What benefits does your position provide? Is this a fair way to score a company, or do you think there is a better way